Results

Total Results: 1,939 records

Showing results for "event".

  1. Appendixes A-I (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-appendices.pdf
    January 16, 2023 - Any adverse event for high-THC versus placebo (short term, 1 to 6 months followup) Abbreviations … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event.
  2. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
    April 01, 2007 - Adverse Event Detection, Processing, and Reporting The U.S. … Food and Drug Administration defines an adverse event (AE) as any untoward medical occurrence in a patient … AEs are categorized according to the seriousness and, for drugs, the expectedness of the event. … for all marketed products is dependent on the principle of “becoming aware,” collection of adverse event
  3. effectivehealthcare.ahrq.gov/products/antidepressants-update/research-protocol
    July 13, 2011 - phases, it is considered part of the same depressive episode Summary of Protocol Amendments In the event
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
    July 13, 2011 - Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/glucocorticoid-injections_clinician.pdf
    June 01, 2016 - A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis: A Brief Summary of Findings for Clinicians A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis: A Brief Summary of Findings for Clinicians KEY CLINICAL ISSUE What are the relative effectiveness and adverse effect…
  6. effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
    April 01, 2020 - CER 229 Evidence Summary: Opioid Treatments for Chronic Pain Purpose of Review To assess the effectiveness and harms of opioid therapy for chronic noncancer pain, alternative opioid dosing strategies, and risk mitigation strategies Key Messages • Opioids are associated with small improvements versus placebo in …
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-treatments-chronic-pain.pdf
    December 01, 2021 - • All drug classes: Withdrawal from treatment due to adverse events (any adverse event, not specifically … nonsignificant increase in risk of nausea with THC/CBD No change in conclusions Abbreviations: AE=adverse event … with increased risk of withdrawal versus placebo (2.1% vs. 0%, p>0.05).6 The most common adverse event
  8. effectivehealthcare.ahrq.gov/products/antipsychotics-adults/research
    August 14, 2012 - Current Page Topic Timeline Dec. 16, 2009 Topic Initiated Dec. 1, 2010 Research Protocol Aug. 14, 2012 Systematic Review Mar. 30, 2015 Surveillance Report First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness Systematic Review Archived August 14, 2012 Web Version [NLM Site] …
  9. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-surveillance-report-3.pdf
    May 01, 2022 - • Other key adverse event outcomes (i.e., psychosis, cannabis use disorder, cognitive deficits) … ) Insufficient (1) Abbreviations: CBD = cannabidiol; CBDV = cannabidivarin; SAE = serious adverse event … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event
  10. effectivehealthcare.ahrq.gov/products/carioverter-difibrillators/abstract
    April 14, 2010 - Real World Effectiveness of Implantable Cardioverter Defibrillators (ICDs) in Medicare Patients Abstract Archived April 14, 2010 Topic Abstract Background: Although ICDs provide meaningful prolongation of life for patients in clinical trials at high risk for sudden cardiac death (SCD), data are lack…
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
    January 17, 2014 - Update Topic Brief CER 27 NSD FINAL_SJ final Oral Diabetes Medications for Adults with Type 2 Diabetes Nomination Summary Document Results of Topic Selectio…
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-surgery-preparation_research-protocol.pdf
    March 26, 2013 - This cutoff is chosen to ensure that studies can estimate low event rates with adequate precision.b … example, assuming the true incidence proportion is 0.01 (=1%) the probability of observing at least one event … evaluate (and if statistical analyses are deemed appropriate, to estimate more precisely) the adverse event … Study-level or summary estimates of event rates will also be used to contextualize the relative effects … In the event of protocol amendments, the date of each amendment will be accompanied by a description
  13. effectivehealthcare.ahrq.gov/sites/default/files/dyspnea-advanced-cancer-summary-1.pdf
    November 01, 2020 - • Both nonpharmacological and pharmacological interventions led to adverse event-related dropouts
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
    January 01, 2010 - Effective Health Care Topic Number: 0285 Document Completion Date: 3-22-11 1 Results of Topic Selection Process & Next Steps  Pharmacogenetic testing for CYP2C19 variants for guiding antiplatelet treatment will go forward for refinement as a systematic review. The scope of this topic, including p…
  15. effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research
    September 25, 2013 - Current Page Topic Timeline Aug. 4, 2010 Topic Suggestion Nov. 22, 2011 Research Protocol Sep. 25, 2013 Systematic Review Feb. 13, 2014 Disposition of Comments Report Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment Systematic Review Archived September 25, 2013 Web Version [NL…
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
    December 01, 2017 - Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary Comparative Effectiveness Review Number 202 Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma Evidence Summary Objectives and Rationale for Review This report summarizes a systematic review, “E…
  17. Moyer_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/moyer_eccs2012.pdf
    January 01, 2012 - Slide 7: The  Mammography Firestorm • This was a sentinel event in  the history of the U.S.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
    September 23, 2016 - Contacting Authors: In the event that information regarding methods or results appear to be omitted
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
    February 01, 2008 - health and adverse events (along with their definitions) will be collected if applicable including the event … In the event that there is more than one newer antiepileptic drug being compared with an older antiepileptic … separate trial) by dividing the older antiepileptic drug group equally between the comparisons.44 In the event … referral or primary care population) Population Events rates markedly different than in community Event … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will
  20. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/peripheral-artery-disease-pad-defined-as-peripheral-artery-disease-of-the-lower-extremities-1-does-aspirin-reduce-the-risk-of-adverse-cardiovascular-events-mi-stroke-cardiovascular-death-in-patients-with-pad-is-there-a-differ
    January 20, 2011 - Home » Get Involved » Nominated Topics » Topic Suggestion Description Topic Suggestion Description Date submitted: January 20, 2011 Download Topic Suggestion Disposition [PDF · 143.5 KB] Briefly describe a specific question, or set of related questions, about a healt…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: